Supraaortic arteries: contrast material dose reduction at 3.0-T high-spatial-resolution MR angiography--feasibility study.
about
Introduction to Cardiovascular Magnetic Resonance: Technical Principles and Clinical ApplicationsCombined low-dose contrast-enhanced MR angiography and perfusion for acute ischemic stroke at 3T: A more efficient stroke protocol.Magnetic resonance angiography: current status and future directions.Comparative analysis of fluorescent angiography, computed tomographic angiography and magnetic resonance angiography for planning autologous breast reconstruction.Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols.Comparison of extracranial artery stenosis and cerebral blood flow, assessed by quantitative magnetic resonance, using digital subtraction angiography as the reference standard.Effectiveness of MR angiography for the primary diagnosis of acute pulmonary embolism: clinical outcomes at 3 months and 1 year.Appropriate Minimal Dose of Gadobutrol for 3D Time-Resolved MRA of the Supra-Aortic Arteries: Comparison with Conventional Single-Phase High-Resolution 3D Contrast-Enhanced MRA.Recent advances in 3D time-resolved contrast-enhanced MR angiography.Multicenter, intraindividual comparison of single-dose gadobenate dimeglumine and double-dose gadopentetate dimeglumine for MR angiography of the supra-aortic arteries (the Supra-Aortic VALUE study).Non-enhanced versus low-dose contrast-enhanced renal magnetic resonance angiography at 7 T: a feasibility study.Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children.Noninvasive aortic imaging.
P2860
Q26749269-FA8C2C43-C0A2-4598-9B13-5291143C042EQ34155336-295EFDD9-E755-4D61-808A-8DC06A0CAE96Q34698936-1D0301DD-C2DE-4585-A97B-B1D9ECA67F81Q35537751-3D3F98CE-1FE6-47F3-B842-FFB99B2C67D8Q36974375-B8145017-EB52-4B1B-80E2-FA82B8F6E4D5Q37433024-3D03F4A1-A157-4575-BFCF-5A08884D3EB0Q37673409-BC685357-D012-4852-BE6A-7C336B532E16Q38403233-07AFF57A-8E54-4958-980F-CCEADE8945A0Q40880938-0DAC111D-550F-4254-A317-0B75646CBD5EQ45173741-2ADA7E7D-8ED7-403B-9CD2-8822B5D05732Q48203811-3CBE111F-1616-4E92-B097-56F2AB3EA58CQ48280965-7426BA0C-BA73-4399-B964-80689CB7E54DQ55339099-CF351DD8-C460-44B9-94C7-98E8B218F969
P2860
Supraaortic arteries: contrast material dose reduction at 3.0-T high-spatial-resolution MR angiography--feasibility study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Supraaortic arteries: contrast ...... ngiography--feasibility study.
@en
Supraaortic arteries: contrast ...... ngiography--feasibility study.
@nl
type
label
Supraaortic arteries: contrast ...... ngiography--feasibility study.
@en
Supraaortic arteries: contrast ...... ngiography--feasibility study.
@nl
prefLabel
Supraaortic arteries: contrast ...... ngiography--feasibility study.
@en
Supraaortic arteries: contrast ...... ngiography--feasibility study.
@nl
P2093
P1433
P1476
Supraaortic arteries: contrast ...... ngiography--feasibility study.
@en
P2093
Anderanik Tomasian
Derek G Lohan
J Pablo Villablanca
J Paul Finn
Mehdi Jalili
Noriko Salamon
P304
P356
10.1148/RADIOL.2493080209
P407
P577
2008-12-01T00:00:00Z